Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular Risk Management: A Call for Submissions to Current Clinical Pharmacology.

Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular Risk Management: A Call for Submissions to Current Clinical Pharmacology. Curr Clin Pharmacol. 2020;15(1):2-3 Authors: Mangoni AA, Erre GL PMID: 32407260 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32407260?dopt=Abstract

Source: Current Clinical Pharmacology - May 15, 2020 Category: Drugs & Pharmacology Authors: Mangoni AA, Erre GL Tags: Curr Clin Pharmacol Source Type: research

More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Science